Colon Neoplasm

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

C
CENTOGENEGermany - Rostock
1 program
Peptide-based Immunization for Colon- and and Pancreas-carcinomaN/APeptide1 trial
Active Trials
NCT03871790Completed50Est. Aug 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CENTOGENEPeptide-based Immunization for Colon- and and Pancreas-carcinoma

Clinical Trials (1)

Total enrollment: 50 patients across 1 trials

NCT03871790CENTOGENEPeptide-based Immunization for Colon- and and Pancreas-carcinoma

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

Start: Apr 2019Est. completion: Aug 202250 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space